These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28615284)

  • 1.
    Ho MF; Ingle JN; Bongartz T; Kalari KR; Goss PE; Shepherd LE; Mushiroda T; Kubo M; Wang L; Weinshilboum RM
    Mol Pharmacol; 2017 Aug; 92(2):175-184. PubMed ID: 28615284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.
    Ho MF; Bongartz T; Liu M; Kalari KR; Goss PE; Shepherd LE; Goetz MP; Kubo M; Ingle JN; Wang L; Weinshilboum RM
    Mol Endocrinol; 2016 Mar; 30(3):382-98. PubMed ID: 26866883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression.
    Liu M; Wang L; Bongartz T; Hawse JR; Markovic SN; Schaid DJ; Mushiroda T; Kubo M; Nakamura Y; Kamatani N; Goss PE; Ingle JN; Weinshilboum RM
    Breast Cancer Res; 2012 Mar; 14(2):R41. PubMed ID: 22405131
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ho MF; Lummertz da Rocha E; Zhang C; Ingle JN; Goss PE; Shepherd LE; Kubo M; Wang L; Li H; Weinshilboum RM
    J Pharmacol Exp Ther; 2018 Jun; 365(3):700-710. PubMed ID: 29592948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Mediator Pharmacogenomics:
    Ho MF; Weinshilboum RM
    J Nat Sci; 2017 Aug; 3(8):. PubMed ID: 28868359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
    Ingle JN; Schaid DJ; Goss PE; Liu M; Mushiroda T; Chapman JA; Kubo M; Jenkins GD; Batzler A; Shepherd L; Pater J; Wang L; Ellis MJ; Stearns V; Rohrer DC; Goetz MP; Pritchard KI; Flockhart DA; Nakamura Y; Weinshilboum RM
    J Clin Oncol; 2010 Nov; 28(31):4674-82. PubMed ID: 20876420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin.
    Kong X; Wu SH; Zhang L; Chen XQ
    Mol Med Rep; 2015 Jul; 12(1):895-904. PubMed ID: 25760938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB activation via MyD88-dependent Toll-like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol.
    Sugiyama K; Muroi M; Kinoshita M; Hamada O; Minai Y; Sugita-Konishi Y; Kamata Y; Tanamoto K
    J Toxicol Sci; 2016 Apr; 41(2):273-9. PubMed ID: 26961612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion.
    Qin S; Ingle JN; Liu M; Yu J; Wickerham DL; Kubo M; Weinshilboum RM; Wang L
    Breast Cancer Res; 2017 Aug; 19(1):95. PubMed ID: 28821270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation?
    Mandrekar P; Dolganiuc A; Bellerose G; Kodys K; Romics L; Nizamani R; Szabo G
    Alcohol Clin Exp Res; 2002 Nov; 26(11):1609-14. PubMed ID: 12436048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TLR2 ligand FSL-1 and the TLR5 ligand Flagellin mediate pro-inflammatory and pro-labour response via MyD88/TRAF6/NF-κB-dependent signalling.
    Lim R; Barker G; Lappas M
    Am J Reprod Immunol; 2014 May; 71(5):401-17. PubMed ID: 24635133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappaB transactivation in Saos2 cells requires the Akt/protein kinase B kinase.
    Cenni V; Sirri A; De Pol A; Maraldi NM; Marmiroli S
    Biochem J; 2003 Nov; 376(Pt 1):303-11. PubMed ID: 12906710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B.
    Asehnoune K; Strassheim D; Mitra S; Kim JY; Abraham E
    J Immunol; 2004 Feb; 172(4):2522-9. PubMed ID: 14764725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid activation of nuclear factor κB by 17β-estradiol and selective estrogen receptor modulators: pathways mediating cellular protection.
    Stice JP; Mbai FN; Chen L; Knowlton AA
    Shock; 2012 Aug; 38(2):128-36. PubMed ID: 22683727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
    Gohda J; Matsumura T; Inoue J
    J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.
    Tian J; Guo X; Liu XM; Liu L; Weng QF; Dong SJ; Knowlton AA; Yuan WJ; Lin L
    Cardiovasc Res; 2013 Jun; 98(3):391-401. PubMed ID: 23447644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.